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Growth retarded fetuses and neonates have higher morbidity and mortality rates than normally developed infants of comparable age [4, 5, 16, 19, 20, 24] . During the immediate neonatal period, smallfor-date infants run an increased risk of infection, are particularly prone to hypoglycemia and have difficulties in maintaining normal body temperature. Subsequently some of these infants will not attain normal body size, and a considerable number will suffer from neurologic impairment [8, 10, 23] . Early detection of intrauterine growth retardation (IUGR) and careful monitoring of the affected fetuses, both by biophysical and biochemical means, are of substantial interest to the obstetrician. Once fetal growth retardation is recognized, the obstetrician will attempt to normalize fetal growth during the further course of the pregnancy by elimination of maternal causes contributing to the gestational disorder (nicotine, drug abuse, maternal malnutrition, etc.) or by intensive therapy of accompanying maternal complications (toxemia, gestational diabetes, etc ? ) In some cases, early delivery of a viable fetus will be accomplished before irreversible damage or death has occurred. During the 2nd and 3rd trimester of pregnancy, the major proportion of estriol circulating in maternal blood and being excreted through maternal urine and feces is synthesized in the fetoplacental unit [6, 7] . Normal maternal plasma estriol levels indicate fetal well-being, whereas abnormal estriol profiles are mostly associated with abnormal fetal development or fetal distress [14] . The study was designed to examine the possibilities of predicting fetal growth retardation äs early äs during the 2nd trimester of pregnancy by means of total and unconjugated estriol assay in maternal plasma and to compare the usefulness of these two feto-placental function tests in the antepartum Identification of growth retardation.
l Patients and materials
In 583 pregnancies at 15 to 42 gestational weeks, 913 plasma samples of peripheral maternal venous blood were assayed for their concentrations of total estriol and unconjugated estriol. Among the pregnancies examined there were 463 mothers who were delivered of a healthy singleton infant of normal birthweight. These women contributed 707 plasma samples to this study. Normal birthweight was defined äs being between the lOth and 90th percentiles for gestational age according to the birthweight curves of NICKL [25] , which describe the relative frequency of birthweights by week of gestation for the German population in the 1960s. Gestational age was determined by the clinical criteria proposed by FARR [9] and PE-TRUSSA [26] which are based upon estimations of neonatal maturity. irlol wiw oximeted IVom 0,0i ml wllh »t ml iiher, MubniH|uon(ly ! ml ofllw (Mlioi ρίπικο \v»s ^Ivon (o m\oh οΓ RIA lulw»! ovrtponUed HU Ιΐιοωΐφΐιΐχ ilriotl, ω J, described. The extraction yield amounted to 98.1 ± 1.2% äs measured by the recovery of known quantities of tritium-labelled estriol. Estriol quantitation was carried out by means of a radioimmunoassay which followed in essence the procedure described by TULCHINSKY and ABRA-HAM [29] . The estriol extracted was incubated with estriol antiserum and labelled estriol in 0.04 M phosphate buffer pH 7.4 with 0.1% bovine serum albumin added at 0° to 4 °C for 120 minutes. Unbound estriol was then separated from antiserum bound estriol by the addition of a charcoal/dextran Suspension (l mg charcoal per tube). After centrifugation the radioactivity of the supernatant was measured in a liquid scintillation counter. The estriol concentrations of the samples assayed were calculated using a special Computer program. The estriol antiserum used was raised in rabbits through repeated injections of a conjugate of estriol-6-(0-carboxymethyl)oxim with BSA äs immunogen (SORIN BIOMEDICA, Saluggia, Italy). This antiserum had a cross-reaction of 0.01% with estradiol and 0.001% with estrone at 50% displacement. As tracer 2,4,6,7-3 H-(N) estriol was used up to 0.5 (18.5 KBq) for 100 samples. In the ränge of 10 and 100 pg estriol per RIA tube, the intra-assay and inter-assay Variation coefficients were 5.1% and 6.9%. Using the RIA System, the lowest detectable amount of estriol was 6 ± 2 pg. The recovery of known estriol amounts added to plasma samples was at 96% nearly quantitative. pregnancies with normal weight and healthy outcome. Taken äs a whole, the values were similar to the reference values recently reported by FRE-SINSKY, CASTANIER, GRENIER and SCHOLLER [11] . Due to the fact that there were asymmetrical distributions of the hormone concentrations, the estriol figures were represented äs percentiles. As values of comparison to the medians, the appropriate arithemetical means were given in the estriol tabulation. The median total estriol concentrations were in general slightly lower than their means, indicating a denser aggregation of the estriol values below the means than above them. Commencing with the gestational weeks 35 to 36, the wellknown steep rise in total estriol concentrations could be noticed. This was associated with a wide scatter of single values up to and above 400 ng/ml. The 15th percentiles for total plasma estriol which were used äs thresholds i« the characterization of abnormally low steroid levels and äs upper screening limits of a fetal danger zone, showed a marked increase from 5 to 21 ng/ml early in the 2nd trimester. They then lay between 25 and 40 ng/ml in the gestational weeks 25 to 32, and rose to values of approximately 45 to 65 ng/ml between weeks 33 and 38. Later on, the 15th percentiles of total plasma estriol varied between 85 and 95 ng/ml.
Unconjugated estriol in pregnancies with normal outcome
Tab. IV and Fig. 2 show the unconjugated estriol concentrations in mäternal plasma related to gestational age. By comparison of Fig. l and 2 one may easily recognize that there was a close parallel in the shape of the curve äscents for unconjugated and total plasma estriol during the second and third trimester, with the average proportion of unconjugated "estriol varying between 6 and 8% of total estriol. The above^mentioned steep rise of total plasma estriol at gestational weeks 35 to 36 with an associated very wide scatter of some individual values also occurred in the unconjugated estriol fraction. The 15th percentiles for unconjugated estriol in mäternal plasma rose steeply from 0.3 to 1.7 ng/ml between gestational weeks 15 and 24. During the Tab. IV. Means, medians, 95% and 70% confidence limits, and ränges of uncorijugated estriol in maternal pfasma from the pregnancies with normal weight, healthy neonates. weeks 25 to 32 they were 2.1 to 3.4 ng/ml; in the weeks 33 to 38, 3.8 to 4.5 ng/ml; and 5.3 to 5.6 ng/ml during the last four gestational weeks.
Total estriol in pregnancies with intrauterine growth retardation
Tab. V shows the total estriol concentrations in maternal plasma related to gestational age for the pregnancies with small-for-date babies. From comparison of these values with those in pregnancies with normal outcome, it becomes clear that IUGR was associated with low concentrations of maternal plasma estriol, both in the 2nd and in the 3rd trimester. The total estriol medians in the IUGR group lay, with the exception of two values during early 2nd trimester, below those in the reference group. The values strongly diverged especially during the last 6 to 8 weeks of gestation. In this period, the total estriol median curve of the IUGR group lacked the characteristic accelerated increase to be found in the group of pregnancies with normal outcome (Fig. 3) . The absolute and relative distribution of the individual total estriol concentrations measured in the IUGR group within the above-described estriol percentiles System from the pregnancies with normal outcome is represented in Tab The concentrations of unconjugated estriol in maternal plasma from pregnancies with IUGR showed a rather similar trend towards their total estriol counterparts. They were substantially lower in almost all gestational weeks of the 2nd and 3rd trimester compared with their reference val es of the normal outcome group (Tab. VI). The unconjugated estriol medians of the IUGR group lay, with the exception of one value in the early 2nd trimester, always below those f the normal outcome group. As early s the 2nd trimester the divergence of the two median curves was very clear, while in the 3rd trimester it did not appear to be s accentuated s it was in the case of total estriol (Fig. 4) . As can be seen from Tab. VI, VII, in the IUGR group 38.83% of unconjugated estriol val es (1 1.65% plus 27.18%) could be detected below the 15th estriol reference percentiles (gestational weeks 15 to 42), while the corresponding value for total estriol was 36.4% (no statistically significant difference between the two val es).
During the 2nd trimester the relative frequency of unconjugated estriol values in the IUGR group encountered below the 15th estriol reference percentile was 46.25% (17.50% plus 28.75%). This is in contrast to only 34.13% during the 3rd trimester (7.94% plus 26.19%); (Tab. VII).
Total and unconjugated estriol in pregnancies with intrauterine growth retardation
Fig . 5 demonstrates that in the course of the 2nd s well s of the 3rd trimester both total and unconjugated plasma estriol levels were significantly lower in the IUGR group compared with the estriol levels in the group with normal outcome. Separate evaluations of total and unconjugated estriol concentrations in women with severe or mild forms of fetal growth retardation (infants below the 3rd or the lOth birthweight percentiles) did not reveal any clear differences between the hormone levels in the two weight categories of IUGR pregnancies. Nor did the estriol levels from pregnancies with "pure" IUGR or IUGR associated with toxemia characteristically differ from each other. The failure of serial low plasma estriol levels to show the characteristic rise which is commonly observed during the 3rd trimester of pregnancies with normal outcome was described by KLOPPER, JANDIAL and WILSON [21] äs a reliable sign of intrauterine growth retardation. Fig. 6 shows that a similar plasma estriol conduct may be seen already during the 2nd trimester öf pregnancies with IUGR. 
Discussion
The paired hormone assays demonstrated that both total estriol and unconjugated estriol concentrations in maternal plasma tended to be low in pregnancies with intrauterine growth retardation. Under the premise that the 15th percentiles of maternal plasma estriol concentrations in pregnancies with normal outcome were used äs screening limits, 36.40% of the blood specimens from IUGR pregnancies had abnormally low concentrations of total estriol, and 38.83% of them had abnormally low concentrations of unconjugated estriol in the course of the 2nd and 3rd trimester. In the 2nd trimester the predictive value for IUGR of unconjugated plasma estriol was higher than that of total plasma estriol. In the 3rd trimester the Situation was reversed. A clear superiority in predicting IUGR by unconjugated plasma estriol (in comparison with total plasma estriol), äs has been claimed on theoretical considerations by some authors [30] , could not be confirmed in this study.
The prediction of fetal growth retardation by plasma estriol estimations could be made with a similar degree of probability during the 2nd trimester äs during the 3rd; an observation that may attract the attention of the obstetrician and perhaps of the perinatologic pathologist, since it sheds some light on the early onset of this gestational complication.
Studies of plasma estriol with the aim of predecting or monitoring intrauterine growth retardation have been condücted repeatedly [l, 3, 12, 15, 17, 18, 21, 22] . All the$e üivestigations, which dealt almost entirely with IUGR cases in late pregnancy, led to the unequivocal conclusion that in pregnancies with retarded fetal growth the maternal estriol values were commonly lower than normal and that the estriol curves obtained by serial plasma estriol measurements were flattened in comparison with those in pregnancies of comparable gestational age with normal outcome. Less unanimity among the authors existed äs to the rate of true IUGR prediction by plasma estriol. The quotation of accurate predictions by plasma estriol assays ranged from 20% reported by Tow-LER et al. [28] to an astonishingly high 86% reported by GOEBEL et al. [13] in cases of IUGR without hypertension. Evidently some of the discrepancies in the assessment of the predictive valüe of plasma estriol measurements were due to application of different criteria in defining abnormally low estriol levels or birthweight limits for smallfor-dates infants or the use of different hormone assay procedures. Between the plasma estriol concentrations in pregnancies with normal outcome and those with IUGR there was a large area of overlapping, a fact which logically limits the diagnostic usefulness of the measurements. It presently often remains obscure why in one individual case of IUGR the classical low estriol values are found and in another case they are not. In this connection one should keep in mind that the clinical syndrome of intrauterine growth retardation can result from diseases of the mother, the placenta and the fetus, or from special circumstances relating to genetics or maternal environmental setting.
Taking these various roots of IUGR into consideration, it should not be surprising that only a proportion of all IUGR cases can be discovered by feto-placental function tests such äs maternal plasma estriol assay. For example, in a pregnancy complicated by ample placental infarcts and a substantial reduction in maternal-placental Substrate and gas exchange, the investigator may easily find retarded fetal growth associated with abnormally low plasma estriol levels. On the other hand, a pregnant woman who is a severely undernourished drug user with a growth retarded fetus may have normal plasma estriol levels.
In the 2nd and 3rd trimester of gestation maternal plasma estriol is almost entirely a product of the conceptus. Being synthesized by complementary steroidogenic mechanisms in the fetus and placenta, estriol is released from the circulation of the conceptus into the circulation of the pregnant wo-
Summaiy
In 913 plasma samples collected from 583 mothers in the 2nd and 3rd trimester of pregnancy (gestational weeks 15 to 42), paired determinations of total and unconjugated estriol levels were performed by radioimmunoassay. 707 of the samples were taken from 463 mothers who were delivered of healthy singleton normal birthweight infants. The remaining 206 plasmas assayed came from 120 pregnant women who gave birth to singleton small^for-date infants whose birthweight feil below the lOth percentile for gestational age and who were therefore classified äs suffering from intrauterine growth retardation (IUGR). From the levels encounteied in the pregnancies with normal weight outcome, reference values such äs medians, means, 95% and 70% confidence limits of total and unconjugated plasma estriol were calculated for the 2nd and 3rd trimester. Due to the asymmetrical distribütion of the estriol data, their mathemätical representation was predominantly done in percentiles. Values which feil below the 15th plasma estriol percentile for gestational age were regarded äs abnormally low and indicators of ."Potential fetal danger.
In pregnancies with IUGR, total and unconjugated estriol in maternal plasma tended to be lower than in pregnancies with normal weight offspring. The medians of total and unconjugated plasma estriol from the IUGR group lay man. Regulär feto-placental synthesis of estriol requires a sufficient supply of oxygen and steroidal precursors; thus, plasma estriol assays may be used in the assessment of feto-placental function during the 2nd and 3rd trimester of pregnancy [6] , Normal maternl plasma estriol concentrations with a rising tendency in the progression of gestation indicate good outcome. Since plasma estriol measurements can now be carried out readily, precisely, repeatedly and without major molestation to the mother, they are a valuable tool in monitoring and managing pregnancies with chronic complications such äs intrauterine growth retardation, placental insufficiency or postmaturity. Assays of total estriol in amniotic fluid seem to be superior to maternal plasma estriol assays in predicting IUGR in late gestation [2] . Of course, the combined application of different clinical tests such äs ultrasonography, fetal heart monitoring, HPL assays, total estriol, lecithin determinations in amniotic fluid and plasma estriol assays will provide the obstetrician engaged in the management of an IUGR pregnancy with much more useful data than would be obtained with an estriol determination alone.
usually below those from the normal birthweight reference group. During the third trimester the rate of abnormally low total estriol levels from the IUGR group amounted to 41%, while that of abnormally low unconjugated estriol levels was 34%. During the second trimester 29% of the total estriol values and 46% of the unconjugated estriol values from the IUGR group feil below the corresponding 15th estriol percentiles. Generally, the rate of abnormally low maternal plasma estriol levels from the IUGR group in the 2nd and 3rd trimester was almost identical -between 35% and 40% -for the total and the unconjugated estriol. Three riiain conclusions could be drawn from this study: 1. Measurements of total and unconjugated estriol in maternal venous plasma during the 2nd and 3rd trimester of pregnancy were of comparable clinical usefulness. The overäll effiäency of the two estriol tests in discriminating pregnancies with IUGR was 36% for total estriol and 38% for unconjugated estriol. 2. Predictions of IUGR by abnormally low plasma estriol levels could be made with a similar rate of accuracy both during the 2nd and 3rd trimester. 3. Plasma estriol determinations appeared to be most useful when normal estriol results provided some reassurance to the obstetrician that the current Status of the fetus was satisfactory.
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